Skip to main content
main-content

Obesity, diet, & lifestyle interventions


Browse the latest news, expert commentary, and educational content on obesity and lifestyle interventions.


Highlights

04-27-2022 | Tirzepatide | News

Tirzepatide reduces liver fat, improves time in range

The publication of two SURPASS-3 substudies in The Lancet Diabetes & Endocrinology reveals significant benefits of tirzepatide on liver and abdominal fat in people with type 2 diabetes, as well as on time in target glucose range.

03-31-2022 | Diet | Hot topic review | Article

Fasting and people with diabetes

Read this Hot Topic Review to catch up on the latest research into the risks and benefits of fasting for people with diabetes.

03-18-2022 | Cardiovascular outcomes | News

Weight gain and loss may both signal high cardiovascular risk in type 2 diabetes

The gain or loss of more than 5% bodyweight within a 2-year period is associated with an increased risk for major adverse cardiovascular events in people with type 2 diabetes, say researchers.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

More on obesity & lifestyle interventions

DiRECT: Type 2 diabetes remission through weight management

Primary findings, 2-year outcomes and translating this landmark trial into practice

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox